PERRELLI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 1.120
EU - Europa 535
AS - Asia 194
OC - Oceania 2
SA - Sud America 1
Totale 1.852
Nazione #
US - Stati Uniti d'America 1.116
IT - Italia 206
CN - Cina 123
IE - Irlanda 109
SE - Svezia 76
UA - Ucraina 39
VN - Vietnam 27
GB - Regno Unito 22
FR - Francia 17
DE - Germania 14
PL - Polonia 14
HK - Hong Kong 10
KR - Corea 10
BE - Belgio 9
ES - Italia 8
IN - India 8
JP - Giappone 7
NL - Olanda 7
TW - Taiwan 5
CA - Canada 4
DK - Danimarca 3
SG - Singapore 3
RO - Romania 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AU - Australia 1
BG - Bulgaria 1
BY - Bielorussia 1
EC - Ecuador 1
FI - Finlandia 1
HR - Croazia 1
LV - Lettonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RU - Federazione Russa 1
Totale 1.852
Città #
Chandler 221
Ashburn 109
Dublin 109
Fairfield 100
Torino 96
Woodbridge 57
Beijing 51
Seattle 45
Nyköping 42
Houston 41
Jacksonville 39
Wilmington 34
Cambridge 31
Ann Arbor 25
Pisa 24
Medford 20
Princeton 15
Turin 12
Warsaw 12
Boston 11
Dong Ket 11
Fremont 11
San Mateo 11
Xian 11
Milan 10
Dearborn 9
Nanjing 9
Brussels 7
Central District 7
Hangzhou 7
New York 7
Seoul 7
Shanghai 7
Redwood City 6
Norwalk 5
Vigo 5
Villeurbanne 5
Aosta 4
Edinburgh 4
Pune 4
San Diego 4
Taipei 4
Copenhagen 3
Fontana 3
Gouda 3
Guangzhou 3
Gunzenhausen 3
Hefei 3
Kunming 3
Rochester 3
Santiago De Compostela 3
Toronto 3
Baotou 2
Berlin 2
Bromsgrove 2
Chieri 2
Cuneo 2
Feltre 2
Genova 2
Greifswald 2
Hebei 2
Hong Kong 2
Jinan 2
London 2
Mountain View 2
Phoenix 2
Rome 2
Silver Spring 2
Tokyo 2
White Lake 2
Akron 1
Albuquerque 1
Amersfoort 1
Auckland 1
Bethesda 1
Birmingham 1
Bognor Regis 1
Cardiff 1
Changsha 1
Chengdu 1
Chicago 1
Falls Church 1
Gwangju 1
Göttingen 1
Ithaca 1
Kwangju 1
Los Angeles 1
Maastricht 1
Meta 1
Moncalieri 1
Mumbai 1
Nanchang 1
Napoli 1
Oslo 1
Paris 1
Peer 1
Porto 1
Quito 1
Riga 1
Saint Paul 1
Totale 1.345
Nome #
KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease 190
Data in support of sustained upregulation of adaptive redox homeostasis mechanisms caused by KRIT1 loss-of-function 136
Biological activities, health benefits, and therapeutic properties of avenanthramides: From skin protection to prevention and treatment of cerebrovascular diseases 123
Yeast-derived recombinant avenanthramides inhibit proliferation, migration and epithelial mesenchymal transition of colon cancer cells 121
KRIT1 Deficiency Promotes Aortic Endothelial Dysfunction 105
Multifunctional Platinum@BSA-Rapamycin Nanocarriers for the Combinatorial Therapy of Cerebral Cavernous Malformation 101
KRIT1 Loss-Of-Function Associated with Cerebral Cavernous Malformation Disease Leads to Enhanced S-Glutathionylation of Distinct Structural and Regulatory Proteins 98
KRIT1 loss of function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: implication for Cerebral Cavernous Malformation disease 79
Vitamin D deficiency and the risk of cerebrovascular disease 75
Multifunctional platinum@bsa-rapamycin nanocarriers for combinatorial therapy of cerebral cavernous malformation disease 72
KRIT1/CCM1 Loss-of-function Mutations Impair Anti-glycative and Anti-oxidant Systems Worsening High Fructose Diet-induced Hepatic Dismetabolism 71
Identification of risk factors and biomarkers of diagnostic and prognostic value associated with clinical progression and severity of cerebral cavernous malformations 69
Towards precision nanomedicine for cerebrovascular diseases with emphasis on Cerebral Cavernous Malformation (CCM) 66
KRIT1/CCM1 loss-of-function affects sphingolipid metabolism inducing hepatosteatosis and predisposing to liver fibrosis and insulin-resistance 63
Altered redox homeostasis and signaling in Cerebral Cavernous Malformation disease: towards a complex but unifying pathogenic mechanism and therapeutic implications 63
KRIT1/CCM1 loss-of-function impairs advanced glycation endproducts receptors and detoxification and worsens fructose diet-induced hepatic dysmetabolism 62
KRIT1 loss-of-function induces a sustained Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: implication for Cerebral Cavernous Malformation disease 60
Production of KRIT1-knockout and KRIT1-knockin Mouse Embryonic Fibroblasts as Cellular Models of CCM Disease 59
Dicarbonyl stress and s-glutathionylation in cerebrovascular diseases: A focus on cerebral cavernous malformations 56
From Genes and Mechanisms to Molecular-Targeted Therapies: The Long Climb to the Cure of Cerebral Cavernous Malformation (CCM) Disease 51
Protein kinase Cα regulates the nucleocytoplasmic shuttling of KRIT1 46
Fluorescence Analysis of Reactive Oxygen Species (ROS) in Cellular Models of Cerebral Cavernous Malformation Disease 44
Polymorphisms in genes related to oxidative stress and inflammation: Emerging links with the pathogenesis and severity of Cerebral Cavernous Malformation disease 40
KRIT1: A Traffic Warden at the Busy Crossroads Between Redox Signaling and the Pathogenesis of Cerebral Cavernous Malformation Disease 18
Heterozygous Loss of KRIT1 in Mice Affects Metabolic Functions of the Liver, Promoting Hepatic Oxidative and Glycative Stress 17
Multidrug-Loaded Lipid Nanoemulsions for the Combinatorial Treatment of Cerebral Cavernous Malformation Disease 13
Next-Generation Sequencing Advances the Genetic Diagnosis of Cerebral Cavernous Malformation (CCM) 12
Distant Recurrence of a Cerebral Cavernous Malformation in the Vicinity of a Developmental Venous Anomaly: Case Report of Local Oxy-Inflammatory Events 7
Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease 2
Totale 1.919
Categoria #
all - tutte 6.847
article - articoli 0
book - libri 0
conference - conferenze 2.020
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.867


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201969 0 0 0 0 0 0 0 0 0 5 44 20
2019/2020284 14 8 5 32 13 15 39 39 49 26 25 19
2020/2021385 20 33 68 9 27 21 16 40 45 38 27 41
2021/2022362 30 2 17 13 33 8 25 26 5 23 95 85
2022/2023518 53 57 20 76 24 118 32 31 60 8 31 8
2023/2024215 41 58 4 12 10 24 6 50 2 8 0 0
Totale 1.919